Finding 502573 (2023-003)

Significant Deficiency
Requirement
AB
Questioned Costs
-
Year
2023
Accepted
2024-10-12
Audit: 324580
Organization: Okanogan Behavioral Healthcare (WA)

AI Summary

  • Core Issue: There was a significant deficiency in internal controls regarding allowable costs, specifically a lack of documentation for $50 of expenditures.
  • Impacted Requirements: Costs must meet criteria under §200.403 to be allowable and adequately documented for federal awards.
  • Recommended Follow-Up: Ensure all expenditures are properly supported by invoices or documentation and retained for compliance.

Finding Text

Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Substance Abuse Prevention and Treatment Block Grant (SABG) Assistance Listing Number: 93.959 Federal Award Identification Number and Year: K6103.01 – 2023 Pass-Through Agency: Washington State Health Care Authority Pass-Through Number(s): K6103.01 Award Period: July 1, 2022 – June 30, 2023 Type of Finding: Significant Deficiency in Internal Control over Compliance – Allowable Costs and Activities; Other Matters Criteria or specific requirement: Under §200.403, costs must meet specific criteria to be allowable under Federal awards and be adequately documented. Condition: For one transaction selected for testing, support for the disbursement included a vendor invoice for $252.25, however, the amount paid to the vendor on behalf of the client was $302.25 and there was no support for the $50 additional. The grant is a reimbursement-based grant. As such, there was insufficient support for $50 of federal expenditures. Questioned costs: None. Context: Of the nine general disbursements tested for period of performance, one was noted in which the total amount expended was $302.25, however, the supporting invoice was for $252.25, resulting in $50 that was unsupported. Cause: After paying the supported invoice, the client would have had $50 left of eligible grant funds after the bill payment. Program management added the remaining $50 to the expenditure amount to be put towards the client's future power bill. Effect: Support was not available for $50 of program expenditures charged to the grant. Repeat finding: Not a repeat finding. Recommendation: CLA recommends that all expenditures charged to the grant have been incurred and are supported by invoice or other documentation and retained by OBHC. Views of responsible officials: There is no disagreement with the audit finding.

Corrective Action Plan

Action taken in response to finding: The program experienced transition in management and staff during FY23. The new Recovery Support Services staff are now fully trained and ensures expenditures are incurred, charged appropriately and supporting documentation is maintained on file. Additionally, AP and Finance team review supporting documentation and ensure completeness. Name(s) of the contact person(s) responsible for corrective action: Floral Reed Planned completion date for corrective action plan: June 30, 2024

Categories

Allowable Costs / Cost Principles Cash Management Period of Performance Significant Deficiency Internal Control / Segregation of Duties

Other Findings in this Audit

  • 502571 2023-001
    Significant Deficiency Repeat
  • 502572 2023-002
    Significant Deficiency
  • 502574 2023-004
    Significant Deficiency
  • 502575 2023-005
    Significant Deficiency
  • 502576 2023-006
    Material Weakness
  • 502577 2023-007
    Significant Deficiency
  • 502578 2023-008
    Material Weakness
  • 502579 2023-002
    Significant Deficiency
  • 502580 2023-005
    Significant Deficiency
  • 502581 2023-007
    Significant Deficiency
  • 502582 2023-002
    Significant Deficiency
  • 502583 2023-006
    Material Weakness
  • 502584 2023-002
    Significant Deficiency
  • 502585 2023-007
    Significant Deficiency
  • 502586 2023-008
    Material Weakness
  • 1079013 2023-001
    Significant Deficiency Repeat
  • 1079014 2023-002
    Significant Deficiency
  • 1079015 2023-003
    Significant Deficiency
  • 1079016 2023-004
    Significant Deficiency
  • 1079017 2023-005
    Significant Deficiency
  • 1079018 2023-006
    Material Weakness
  • 1079019 2023-007
    Significant Deficiency
  • 1079020 2023-008
    Material Weakness
  • 1079021 2023-002
    Significant Deficiency
  • 1079022 2023-005
    Significant Deficiency
  • 1079023 2023-007
    Significant Deficiency
  • 1079024 2023-002
    Significant Deficiency
  • 1079025 2023-006
    Material Weakness
  • 1079026 2023-002
    Significant Deficiency
  • 1079027 2023-007
    Significant Deficiency
  • 1079028 2023-008
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $407,550
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $130,992
14.267 Continuum of Care Program $75,071
93.665 Emergency Grants to Address Mental and Substance Use Disorders During Covid-19 $60,429
93.958 Block Grants for Community Mental Health Services $42,000
93.959 Block Grants for Prevention and Treatment of Substance Abuse $36,000